Hims & Hers Health (HIMS) Interest Coverage Ratio Growth (1y) (2021 - 2026)
Hims & Hers Health (HIMS) Interest Coverage Ratio Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn | -14.04% |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn | -63.16% |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn | -58.34% |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn | 97.17% |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn | -87.09% |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn | -14.91% |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn | -120.69% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.69% |
| Dec 31, 2025 | -114.30% |
| Sep 30, 2025 | -78.29% |
| Jun 30, 2025 | 19.00% |
| Mar 31, 2025 | 364.28% |
| Dec 31, 2024 | 2,635.82% |
| Sep 30, 2024 | 157.07% |
| Jun 30, 2024 | 148.27% |
| Mar 31, 2024 | 3,018.90% |
| Dec 31, 2023 | 97.70% |
| Sep 30, 2023 | 64.63% |
| Jun 30, 2023 | 87.77% |
| Mar 31, 2023 | 97.91% |
| Dec 31, 2022 | 46.19% |
| Sep 30, 2022 | 96.98% |
| Jun 30, 2022 | -102.37% |
| Mar 31, 2022 | 94.66% |
| Mar 31, 2021 | 79.24% |